Harvard Bioscience Inc reports results for the quarter ended in December - Earnings Summary

Harvard Bioscience

07/03/2024 15:15

* Harvard Bioscience Inc  HBIO.OQ  reported quarterly
adjusted
earnings of 4 cents​​ per share for the quarter ended in
December, identical to the same quarter last year.  The mean
expectation of three analysts for the quarter was for earnings
of 5 cents per share. 
    * Revenue fell 1% to $28.15 million from a year ago;
analysts
expected $29.11 million. 
    * Harvard Bioscience Inc's reported EPS for the quarter was
a loss
of 4 cents​.
    * The company reported a quarterly loss of $1.82 million.
    * Harvard Bioscience Inc shares had fallen by 23.2% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 21%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Harvard
Bioscience Inc is $7.00 
This summary was machine generated from LSEG data March 7 at
03:14 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      0.05           0.04           Missed
 Sep. 30 2023      0.04           0.01           Missed
 Jun. 30 2023      0.06           0.04           Missed
 Mar. 31 2023      0.05           0.06           Beat